Median Technologies SA (EPA: ALMDT)

Market Cap	71.03M
Revenue (ttm)	22.32M
Net Income (ttm)	-25.35M
Shares Out	18.43M
EPS (ttm)	-1.29
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	37,200
Open	3.890
Previous Close	3.975
Day's Range	3.750 - 3.945
52-Week Range	2.000 - 7.760
Beta	1.43
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 24, 2024

About Median Technologies

Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device for early diagnosis of cancers and fibrotic diseases; iSee for image analysis services in clinical trials; and iCRO, which engages in the sale of imaging services for clinical trials in oncology using software. The company was founded in 2002 and is based in Valbonne, ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 256
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALMDT

Financial Performance

In 2023, Median Technologies's revenue was 22.78 million, a decrease of -4.87% compared to the previous year's 23.95 million. Losses were -22.98 million, 13.7% more than in 2022.